No. RFA-AI-27-002 · National Institutes of Health
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Award range
- Not specified
- Expected awards
- Not specified
- Application deadline
- Nov 10, 2026
- Posted
- Sep 1, 2026
- Last verified
- 4 days ago
At a glance
No plain-language summary yet for this grant — the official description below is the best source.
What it funds
Official description from grants.gov
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting a cooperative network to rapidly implement clinical trials that meet NIH and NIAID priorities. The network, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of therapeutics, vaccines, biologics, diagnostics, and devices targeting infectious diseases, including emerging and chronic infections. The initiative gives the NIH the capabilities to conduct clinical trials and studies for public health priorities, where the timelines of a standard, unsolicited grant would not adequately address the needs of the United States population. The CTEUs provide the clinical infrastructure for implementing the clinical trials and studies. The NCC, comprised of leaders from the CTEUs in collaboration with NIAID, provides the administrative and organizational framework of the network, engages with experts in the field to solicit and generate innovative concepts for advancing public health while mentoring the next generation of clinical trialists. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Who can apply
- City or township governments
- County governments
- For-profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Others
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Small businesses
- Special district governments
- State governments
“Faith-based or Community-based Organizations” — From the announcement
Program history
USASpending.govAssistance listing 93.855 · Allergy and Infectious Diseases Research
Real awards this federal program has made — the whole assistance listing (93.855), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 1,817 | $295,722 | $146,402 – $737,210 |
| FY 2025 | 1,596 | — | — |
| FY 2024 | 1,720 | — | — |
| FY 2023 | 1,711 | — | — |
| FY 2022 | 1,576 | — | — |
| FY 2021 | 1,857 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 10,277 — award counts are complete.
- SCRIPPS RESEARCH INSTITUTE $3,679,976 · FY 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE $3,499,366 · FY 2026
- UNIVERSITY OF WASHINGTON $3,414,775 · FY 2026
- UNIVERSITY OF FLORIDA $3,389,992 · FY 2026
- ALBERT EINSTEIN COLLEGE OF MEDICINE $3,204,071 · FY 2026
Source: USASpending.gov · refreshed Aug 23, 2026
Change history
Since we first indexed it- Sep 2, 2026 Status: forecasted → open
- Sep 2, 2026 Deadline set: Nov 10, 2026
- Sep 1, 2026 Title updated